Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - CASI Pharmaceuticals, Inc. | v336076_10k.htm |
| EX-32.1 - EXHIBIT 32.1 - CASI Pharmaceuticals, Inc. | v336076_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - CASI Pharmaceuticals, Inc. | v336076_ex31-2.htm |
| EX-23.1 - EXHIBIT 23.1 - CASI Pharmaceuticals, Inc. | v336076_ex23-1.htm |
| EX-31.1 - EXHIBIT 31.1 - CASI Pharmaceuticals, Inc. | v336076_ex31-1.htm |
| EXCEL - IDEA: XBRL DOCUMENT - CASI Pharmaceuticals, Inc. | Financial_Report.xls |
| EX-32.2 - EXHIBIT 32.2 - CASI Pharmaceuticals, Inc. | v336076_ex32-2.htm |
EXHIBIT 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements:
Registration Statement Number 333-68048 on Form S-8
Registration Statement Number 333-101617 on Form S-8
Registration Statement Number 333-80193 on Form S-3
Registration Statement Number 333-84907 on Form S-3
Registration Statement Number 333-76824 on Form S-3
Registration Statement Number 333-104380 on Form S-3
Registration Statement Number 333-110604 on Form S-3
Registration Statement Number 333-122309 on Form S-3
Registration Statement Number 333-133190 on Form S-3
Registration Statement Number 333-132715 on Form S-3
Registration Statement Number 333-151542 on Form S-3
Registration Statement Number 333-161100 on Form S-3
Registration Statement Number 333-167754 on Form S-3
Registration Statement Number 333-182803 on Form S-3
Registration Statement Number 333-184128 on Form S-3
of our report dated March 9, 2012, with respect to the consolidated financial statements of EntreMed, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2012.
/s/Reznick Group, P.C.
Vienna, Virginia
March 21, 2013